Once, vaccines were the poor relations of therapeutic drugs. Traditional vaccines, the sort used to combat childhood diseases such as measles, polio are a low-tech, low-cost boon to public health programmes around the world, but drug companies regard them as dull and unprofitable. Between 1980 and 1990, the number of big drug companies producing vaccines in America dropped from 12 to four.